home

Self-destructing cells could hold key for brain health and food security

‘Cell suicide’ study could unlock treatment for brain diseases and development of disease-resistant plants. 
Published
Architecture

Griffith scientists celebrate National Science Week 2019 

National Science Week will see a range of events celebrate Griffith's scientific expertise.
Published
Institute for Glycomics

Research provides new hope for treatment of Hand, Foot and Mouth Disease

A new scientific discovery, thanks to one of the research groups at Griffith University’s Institute for Glycomics, is providing new hope for the development of an effective treatment of Hand, Foot and Mouth Disease (HFMD). Led by the Institute’s Founder and Director, Professor Mark von Itzstein AO, the research group has just published a paper […]
Published
Institute for Glycomics

Institute for Glycomics receives US grant for vital cholera research

Griffith’s Institute for Glycomics will share in a significant US funded grant awarded by the National Institute for Health (NIH) for a two-year research project investigating the role of Vibrio cholerae (V. cholerae) in causing widespread cholera epidemics. V. cholerae is a Gram-negative, comma-shaped bacterium/pathogen. The bacterium’s natural habitat is brackish or saltwater. Some strains of […]
Published
Institute for Glycomics

Institute for Glycomics Director appointed high honour of Officer of the Order of Australia

Professor Mark von Itzstein, Founder and Director of Griffith University’s Institute for Glycomics, has been awarded one of Australia’s highest honours, officially being named as an Officer (AO) of the Order of Australia in the General Division. This highly prestigious title, which took effect on 10 June 2019, was approved by the Governor-General, His Excellency […]
Published
Griffith Enterprise

Griffith University research partnership breaking new ground in the development of anti-infective drugs

Scientists from Griffith’s Institute for Glycomics have teamed up with Germany’s Fraunhofer Institute for Toxicology and Experimental Medicine ITEM and the Hannover Medical School to explore novel anti-infective therapeutic concepts as part of the project Fraunhofer iCAIR® (Fraunhofer International Consortium for Anti-Infective Research). The project’s ground-breaking approach and research will be showcased at the Australian and German […]
Published
Australian Rivers Institute

Cheers – charge your glass with a Griffith scientist

Science will be on tap when researchers trade the lab for the pub.
Published
Griffith Enterprise

Institute for Glycomics shares in multi-million dollar grant for ground-breaking gonorrhoea research

The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), has announced awards to establish four Cooperative Research Centres (CRCs) which will focus on the development of vaccines to prevent sexually transmitted infections (STIs). The grants will support collaborative, multidisciplinary research on the pathogens that cause gonorrhoea, chlamydia […]
Published
Griffith Enterprise

Glycomics Circle – empowering women in science

The Institute for Glycomics recognises the value of having women in life sciences. For centuries women have made significant contributions to society, perfectly demonstrated by the fact that 51 women in total have been awarded the Nobel Prize between 1901 and 2018, twenty of which were awarded the Nobel Prize in the fields of physics, […]
Published
Griffith Enterprise

Malaria vaccine trial receives $500,000 in Government support

The Liberal National Government has announced they will donate $500,000 to Griffith University’s Institute for Glycomics to support their ongoing human clinical trials which aim to test the effectiveness of a world-first malaria vaccine candidate named PlasProtecT™. Malaria is caused by an infection with malaria parasites, and is generally characterised by fever, shivering headaches and […]
Published
Health

Institute for Glycomics joins peak body for medical research

Institute becomes member of Association of Australian Medical Research Institutes.
Published
Health

Mosquito-borne diseases: Griffith expert joins live Q&A

Academic offers insights into mosquito-borne diseases for live Q&A symposium.
Published
home

Governor-General visits Griffith for update on malaria vaccine trial

The Governor-General, His Excellency General the Honourable Sir Peter Cosgrove AK MC (Retd), got first-hand insights into the world’s first human clinical trials of a whole parasite blood-stage malaria vaccine when he visited the Institute for Glycomics. In what was one of his last duties before retiring in March, General Cosgrove was given a tour and updates on the […]
Published
Institute for Glycomics

Glycomics Grand Ball Night featuring comedian Arj Barker

Griffith University’s Institute for Glycomics will host its annual Grand Ball Night on Saturday 12 October at RACV Royal Pines Resort. The elegant black-tie affair will be presented by Griffith alumni Eva Milic from Channel 9 Gold Coast News, one of the Media Partners for this year’s event. Hundreds of high-profile, influential guests from Gold […]
Published
Griffith Enterprise

Scientists make breakthrough in search for gonorrhoea vaccination

Public health problem takes on 'superbug' status
Published
Griffith Enterprise

Alzheimer’s drug may help battle antibiotic resistance

Drug originally proposed to treat Alzheimer’s disease has potential to combat dangerous antibiotic-resistant bacteria.
Published
Health

Griffith shares in $5 million for ground-breaking stroke research

A Griffith researcher has shared in a $5 million grant to develop ground-breaking research on stroke prevention. The Heart Foundation announced Professor Michael Good, from Griffith’s Institute for Glycomics, as one of the two Australian researchers who will share in the one-off grant open to researchers who could demonstrate they were working on innovative, internationally […]
Published
home

Hope for new blood test to detect early stage ovarian cancer

Potential to improve early detection of disease possible with new test.
Published